1. Yiling Pharmaceutical always takes the innovation of traditional Chinese medicine as the core, and has formed a unique operation mode of "theory-clinic-scientific research-industry-teaching", and has continuously increased investment in research and development, transforming traditional Chinese medicine prescriptions into medicines and clinical achievements through current technology, and finally forming an innovative exclusive product system. Among them, innovative patented Chinese medicines such as Tongxinluo Capsule, Shen Song Yangxin Capsule and Lianhua Qingwen Capsule/Granule have become the main reasons for Yiling's performance growth.
Second, Yiling Pharmaceutical has continuously strengthened the research of evidence-based medicine to further enhance the clinical value of its products. On June 24th, 2023 10, the paper "Study on the Myocardial Protection of China Tongxinluo in the Treatment of Acute Myocardial Infarction" was published in the Journal of American Medical Association, one of the four international authoritative medical journals (the impact factor was 120.7). The results showed that Tongxinluo, an innovative Chinese medicine in Yiling, could reduce the death risk of acute myocardial infarction by about 30%.
Third, in addition to the innovation of traditional Chinese medicine, Yiling Pharmaceutical has also "broken the circle" into biochemical medicine, big health and other fields. In terms of chemical drugs, four first-class innovative drugs in Yiling Pharmaceutical have entered the clinical stage, and many first-class innovative drugs are in the preclinical research stage. At the end of big health products, Yiling Pharmaceutical has laid out five series of products: dredging collaterals, lowering three highs, nourishing essence and resisting aging, moving products, calming the mind and sleeping peacefully, and picking flowers and breathing health.